Cochrane Abstracts
Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sclerotherapy Versus Beta‐blockers for Primary Prophylaxis of Oesophageal Variceal Bleeding in Children and Adolescents With Chronic Liver Disease or Portal Vein Thrombosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/Sclerotherapy_versus_beta‐blockers_for_primary_prophylaxis_of_oesophageal_variceal_bleeding_in_children_and_adolescents_with_chronic_liver_disease_or_portal_vein_thrombosis.
Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/Sclerotherapy_versus_beta‐blockers_for_primary_prophylaxis_of_oesophageal_variceal_bleeding_in_children_and_adolescents_with_chronic_liver_disease_or_portal_vein_thrombosis. Accessed January 21, 2026.
Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/Sclerotherapy_versus_beta‐blockers_for_primary_prophylaxis_of_oesophageal_variceal_bleeding_in_children_and_adolescents_with_chronic_liver_disease_or_portal_vein_thrombosis
Sclerotherapy Versus Beta‐blockers for Primary Prophylaxis of Oesophageal Variceal Bleeding in Children and Adolescents With Chronic Liver Disease or Portal Vein Thrombosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/Sclerotherapy_versus_beta‐blockers_for_primary_prophylaxis_of_oesophageal_variceal_bleeding_in_children_and_adolescents_with_chronic_liver_disease_or_portal_vein_thrombosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
ID - 438073
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/Sclerotherapy_versus_beta‐blockers_for_primary_prophylaxis_of_oesophageal_variceal_bleeding_in_children_and_adolescents_with_chronic_liver_disease_or_portal_vein_thrombosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
